Results 1 to 10 of about 111,089 (390)

A fully magnetically levitated left ventricular assist device — final report [PDF]

New England Journal of Medicine, 2019
Background In two interim analyses of this trial, patients with advanced heart failure who were treated with a fully magnetically levitated centrifugal‐flow left ventricular assist device were less likely to have pump thrombosis or nondisabling stroke ...
Ewald, G.A., Itoh, A.
core   +3 more sources

Pressure, Flow Rate and Operating Speed Characteristics of a Continuous Flow Left Ventricular Assist Device During Varying Speed Support [PDF]

IEEE Access, 2020
Hydraulic performance of Continuous Flow Left Ventricular Assist Devices depends on their pressure head and flow rate relations. Hydraulic characteristics of these devices are expressed by pressure head and flow rate loops in a pulsatile environment as ...
Selim Bozkurt
doaj   +4 more sources

Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure [PDF]

New England Journal of Medicine, 2001
BACKGROUND Implantable left ventricular assist devices have benefited patients with end-stage heart failure as a bridge to cardiac transplantation, but their long-term use for the purpose of enhancing survival and the quality of life has not been ...
Eric A. Rose, Annetine C. Gelijns, Alan J. Moskowitz, Daniel F. Heitjan, Lynne Warner Stevenson, Walter P. Dembitsky, James W. Long, Deborah D. Ascheim, Anita R. Tierney, Ronald G. Levitan, John T. Watson, Nuala S. Ronan, Peter A. Shapiro, Ronald M. Lazar, Leslie W. Miller, Lopa Gupta, O.H. Frazier, Patrice Desvigne‐Nickens, Mehmet C. Öz, Victor L. Poirier, Paul Meier   +20 more
openalex   +2 more sources

Ethical challenges with the left ventricular assist device as a destination therapy [PDF]

Philosophy, Ethics, and Humanities in Medicine, 2008
The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure.
Rady Mohamed Y, Verheijde Joseph L, Rizzieri Aaron G, McGregor Joan L   +3 more
doaj   +4 more sources

Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims The continuous flow left ventricular assist device (cf-LVAD) has improved the survival of chronic end-stage heart failure (HF) patients.
Yoonjee Park, Darae Kim, Jeong Hoon Yang, Yang Hyun Cho, Jin-Oh Choi, Eun-Seok Jeon   +5 more
doaj   +1 more source

Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2023
IMPORTANCE Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity.
M. Mehra, I. Netuka, N. Uriel, Jason N. Katz, Francis D. Pagani, U. Jorde, F. Gustafsson, Jean M. Connors, P. Ivák, Jennifer Cowger, J. Ransom, Aditya Bansal, Koji Takeda, Richa Agarwal, M. Byku, M. Givertz, Abbas Bitar, Shelley Hall, Daniel Zimpfer, J. D. Vega, Manreet K. Kanwar, Omar Saeed, Daniel J. Goldstein, Rebecca Cogswell, F. Sheikh, Matthew Danter, Y. Pya, Anita Phancao, J. Henderson, D. Crandall, Kartik Sundareswaran, Edward Soltesz, Jerry D. Estep, S.C. Silvestry, A. Tatooles, Nasir Siulemanjee, Brett Sheridan, Sanjeev Gulati, Eugene Chung, Clement Delmas, Carmelo Milano, Pierre Dos Santos, Pavan Atluri, D. Horstmanshof, David D'Alessandro, Sriram Nathan, Peter Eckman, Anelechi Anyanwu, A. Scandroglio, A. Ortalda, Ezequiel J. Molina, Jacob Abraham, Sern Lim, Robert Adamson, Ashwin K. Ravichandran, Christopher Hayward, W. Hiesinger, John Entwistle, Jennifer Conway, Eric Adler, J. Grinstein, A. Brieke, Mary Keebler, Jeffrey D. Alexis, Igor Gosev, Craig Selzman, David M Kaye   +66 more
semanticscholar   +1 more source

Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants

European Journal of Heart Failure, 2021
The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over the HeartMate II axial‐flow pump.
M. Mehra, J. Cleveland, N. Uriel, J. Cowger, S. Hall, D. Horstmanshof, Y. Naka, C. Salerno, J. Chuang, Christopher Williams, D. Goldstein   +10 more
semanticscholar   +1 more source

Racial and Sex Inequities in the Use of and Outcomes After Left Ventricular Assist Device Implantation Among Medicare Beneficiaries

JAMA Network Open, 2022
This cohort study assesses inequities in access and outcomes in the receipt of left ventricular assist device (LVAD) therapy for Black and female patients in the US.
T. Cascino, S. Somanchi, Monica M Colvin, Grace S Chung, A. Brescia, M. Pienta, M. Thompson, James W. Stewart, Devraj Sukul, Daphne C. Watkins, F. Pagani, D. Likosky, K. Aaronson, J. McCullough   +13 more
semanticscholar   +1 more source

Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock

BMC Cardiovascular Disorders, 2022
Background Extracorporeal left ventricular assist device is often required for acute myocardial infarction patients in cardiogenic shock when temporary mechanical circulatory support fails to provide hemodynamic stabilization.
Chiho Tokunaga, Atsushi Iguchi, Hiroyuki Nakajima, Fumiya Chubachi, Yuto Hori, Akitoshi Takazawa, Jun Hayashi, Toshihisa Asakura, Akihiro Yoshitake   +8 more
doaj   +1 more source

Right ventricular failure after left ventricular assist device implantation: a review of the literature

Journal of Thoracic Disease, 2021
Right ventricular failure (RVF) following left ventricular assist device (LVAD) implantation remains a major complication which may significantly impair patient outcome. The genesis of RVF is, however, multifactorial, and the mechanisms underlying such a
V. Lo Coco, M. D. De Piero, Giulio Massimi, Giovanni Chiarini, G. Raffa, M. Kowalewski, J. Maessen, R. Lorusso   +7 more
semanticscholar   +1 more source